glp 1 drugs in india The Controller of has intensified regulatory surveillance against unauthorized sale and promotion of GLP-1 based Weight Loss Drugs. The move comes amid growing concerns over the increasing availability of multiple Inside OneSource: India’s Next Big
Description
V.et al (2015)
Meier JJ, Gallwitz B, Siepmann N, et al
V., Marina, A
But the higher doses required for weight loss (absent a diabetes diagnosis) create more side effects, and at the end of the day, they arent cost-effective
doi: 10.1002/mnfr.201500771
What about combining both medications
